SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 61 of 100
Health
Biotech Stocks Plunge After Trump Says Pharma Is ‘Getting Away With Murder’ on Drug Prices
By
Sy Mukherjee
January 11, 2017
Health
This Revolutionary New Tech Uses Light to Activate Medicine
By
Sy Mukherjee
January 4, 2017
Health
The Perils of Polypharmacy
By
Clifton Leaf
January 3, 2017
Health
5 Major Trends That Shaped Biopharma’s 2016
By
Sy Mukherjee
December 26, 2016
Leadership
Here’s Why Investors Weren’t Excited About Biogen’s New CEO
By
Reuters
December 20, 2016
Health
Mylan Will Start Selling Its Generic EpiPen at a Major Discount
By
Reuters
December 16, 2016
Health
20 States Are Suing Mylan and Other Drug Companies for Allegedly Fixing Prices
By
Reuters
and
Michelle Toh
December 16, 2016
Health
Merck Won a Mammoth $2.5 Billion from Gilead After Its Hepatitis C Drug Patent Suit
By
Reuters
December 16, 2016
Health
Why Did New Drug Approvals in the U.S. Plunge This Year?
By
Sy Mukherjee
December 15, 2016
Health
KKR Just Sold This Drug Delivery Company for $5.5 Billion
By
Reuters
December 15, 2016
Health
Insurers are Rebelling Against the FDA’s Most Controversial 2016 Drug Approval
By
Sy Mukherjee
December 14, 2016
Health
A New Suitor Has Reportedly Replaced J&J in This Over $20 Billion Biotech Deal
By
Reuters
December 14, 2016
Health
Big Pharma Just Had a Terrible, Horrible, No Good, Very Bad Week of Job Cuts
By
Sy Mukherjee
December 12, 2016
Finance
After Valeant, Short-Seller Citron Is Going After This Pharma Benefits Firm
By
Reuters
December 9, 2016
Health
Feds Arrest 6 Former Insys Execs for Allegedly Bribing Doctors
By
Sy Mukherjee
December 8, 2016
Most Popular
Economy
Jerome Powell says the Gen Z hiring nightmare is real: 'Kids coming out of college...are having a hard time finding...
By
Nick Lichtenberg
Banking
Markets expected the rate cut, but the ‘real surprise’ is the Fed’s opinion on the current state of the economy, quant...
By
Amanda Gerut
Economy
Starbucks CEO says the coffee chain won't lose its cash-strapped consumers because it's on its way to being a...
By
Sasha Rogelberg